Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares (NASDAQ: KNSA) last traded at $79.78, up 1.31% on the session. The quote above updates while this page is open; the figures below are drawn from Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares’s own filings and are restated only when a new one is published.
Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares trades on NASDAQ under the ticker KNSA. Its market capitalisation is $6.57 billion.
Valuation measures for Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares, derived from the latest quote and its most recent SEC filing.
| Market cap | $6.57B |
|---|---|
| Enterprise value | $6.60B |
| P/E ratio | 87.67 |
| Price / sales | 8.72 |
| Price / book | 10.85 |
| Beta | 0.22 |
|---|
Trailing-twelve-month figures tagged in Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares's XBRL filings with the SEC.
| Revenue (TTM) | $754.04M |
|---|---|
| Net income (TTM) | $73.06M |
| EPS (TTM) | $0.910 |
| Gross margin | 89.31% |
| Operating margin | 12.36% |
| Return on equity | 12.06% |
| Cash | $189.95M |
Range and volume for KNSA over the past 52 weeks.
| 52-week high | $82.94 |
|---|---|
| 52-week low | $35.20 |
| Volume | 430.3K |
| Average volume | 571.5K |
| Previous close | $78.75 |
Invest a chosen dollar amount in Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell KNSA.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.